ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
105 hedge funds and large institutions have $197M invested in Antares Pharma, Inc. in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
25% less call options, than puts
Call options by funds: $465K | Put options by funds: $617K
Holders
105
Holding in Top 10
2
Calls
$465K
Puts
$617K
Top Buyers
| 1 | +$4.1M | |
| 2 | +$2.32M | |
| 3 | +$1.67M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.66M |
| 5 |
Two Sigma Investments
New York
|
+$882K |
Top Sellers
| 1 | -$9.84M | |
| 2 | -$6.42M | |
| 3 | -$5.64M | |
| 4 |
MWP
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
|
-$924K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$249K |